PAVmed
PAVM
65 hedge funds and large institutions have $19.2M invested in PAVmed in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 9 closing their positions.
91% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 11
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
52% more capital invested
Capital invested by funds: $12.6M → $19.2M (+$6.55M)
8% more funds holding
Funds holding: 60 → 65 (+5)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.22M |
| 2 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$631K |
| 3 |
Morgan Stanley
New York
|
+$553K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$287K |
| 5 |
State Street
Boston,
Massachusetts
|
+$182K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$164K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$63K |
| 3 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$62.4K |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$57.3K |
| 5 |
Squarepoint
New York
|
-$52K |
PAVM Hedge Fund Activity: Q4 2020 in Review
65 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2020, worth a combined $19.2M — up 52% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new PAVM positions and 9 closed out — a net gain of 5 holders — while 21 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.22M. The largest seller was Bank of America, cutting an estimated $164K.
- 65 institutional investors held PAVmed (PAVM) as of Q4 2020, up from 60 in Q3 2020.
- Funds reported $19.2M of PAVmed stock for Q4 2020, up 52% quarter-over-quarter.
- 14 funds opened new PAVmed positions in Q4 2020 and 9 closed out, a net change of +5 holders.
- The largest PAVmed buyer in Q4 2020 was Vanguard Group, an estimated $1.22M added.
- The largest PAVmed seller in Q4 2020 was Bank of America, an estimated $164K sold.
Based on aggregated 13F filings for Q4 2020.